Shares of Fisher & Paykel Healthcare Corporation (ASX: FPH) are soaring 6.09% in intraday trading, as investors react positively to the company's impressive fiscal first-half earnings report. The healthcare equipment manufacturer's strong performance has outpaced the broader Australian market, which is expected to rise following positive cues from Wall Street.

Fisher & Paykel Healthcare reported fiscal first-half earnings of NZ$0.36 per share on revenue of NZ$1.09 billion. This marks a significant improvement from the same period last year when the company posted earnings of NZ$0.26 per share on revenue of NZ$951.2 million. The substantial year-over-year growth in both earnings and revenue has clearly resonated with investors, driving the stock's sharp upward movement.

The company's strong performance comes amid a generally positive sentiment in the Australian market. The ASX is poised to rise following gains in US markets overnight, where major indices climbed on expectations of potential interest rate cuts by the Federal Reserve. While Fisher & Paykel Healthcare's stock surge is primarily attributed to its own financial results, the broader market optimism may be providing additional support to the upward trend.